Vestibular Migraine Clinical Trial
Official title:
A Phase II/III Trial on Rizatriptan for Vestibular Migraine
Suffering from dizzy spells and migraine headaches? Vestibular Migraine (VM), a newly recognized type of migraine that causes bouts of dizziness. University of California, Los Angeles (UCLA) and The Mayo Clinic is seeking people with VM to participate in a research study. The purpose of this study is to look at the natural history of VM and learn more about common symptoms. Investigators also want to learn the effects, both positive and negative, of the commonly used migraine drug, rizatriptan, when it is used for spells of dizziness in people with VM. Patients may be eligible to participate if: - Patients are between the ages of 18 & 65 - Patients have a history of vestibular migraine - Patients are able to maintain a vestibular symptom diary The study includes 3 visits with compensation. All participants must complete questionnaires on dizziness, headache symptoms, general health and well-being, mental health, and a questionnaire on patient's satisfaction with study medication.
The primary Specific Aim is to conduct the first successful controlled study of a treatment for Vestibular Migraine. The investigators hypothesize that rizatriptan will be superior to a look alike inactive capsule for: 1a. Reducing the severity and duration of vertigo attacks in patients with Vestibular Migraine, 1b. Reducing the severity of symptoms commonly associated with vertigo attacks in patients with Vestibular Migraine (e.g., nausea, vomiting, motion sensitivity, gait disturbance, headache, light and sound sensitivity), and 1c. Improving treatment satisfaction and health-related quality of life in patients with Vestibular Migraine, and that 1d. Rizatriptan will be well tolerated by patients with Vestibular Migraine. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Recruiting |
NCT04417361 -
Galcanezumab for Vestibular Migraine
|
Phase 2 | |
Enrolling by invitation |
NCT05396482 -
Assesment of Hearing in Patients With Vestibular Migra
|
||
Completed |
NCT03979677 -
Effects of Lifestyle Modification on Vestibular Migraine
|
N/A | |
Completed |
NCT05157399 -
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
|
N/A | |
Not yet recruiting |
NCT05914207 -
Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent
|
N/A | |
Enrolling by invitation |
NCT06417684 -
Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine
|
Early Phase 1 | |
Recruiting |
NCT04939922 -
China Headache Registry Study
|
||
Recruiting |
NCT05472675 -
Local Sensory Nerve Block in the Treatment of Vestibular Migraine
|
N/A | |
Recruiting |
NCT05418218 -
International Headache Registry Study
|
||
Suspended |
NCT04026516 -
CAVA: Dizziness Trial
|
N/A | |
Withdrawn |
NCT03578354 -
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
|
Phase 2 | |
Completed |
NCT02350985 -
Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine
|
Phase 4 | |
Completed |
NCT03417596 -
Vestibular Rehabilitation in Patients With Vestibular Migraine
|
N/A | |
Not yet recruiting |
NCT04664088 -
Acupuncture for Prophylaxis of Vestibular Migraine
|
N/A | |
Enrolling by invitation |
NCT06267924 -
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
|
N/A | |
Completed |
NCT05960786 -
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
|
N/A | |
Recruiting |
NCT04935970 -
Metabolic Disorders and Vertigo
|
||
Not yet recruiting |
NCT05508139 -
The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients
|
||
Completed |
NCT01669304 -
Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness
|
Phase 1 |